2.4 ML berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML Injection [Keytruda Qlex]
RxNorm concept 2723769, branded drug (sbd). Prescribable name: Keytruda Qlex 395 MG / 4800 UNT in 2.4 ML Injection.
- RxCUI
- 2723769
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2723769 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph 395 MG / 4800 UNT) per 2.4 ML Injection
Related concepts
- pembrolizumab-pmph 165 MG/ML (SCDC, consists of)
- berahyaluronidase alfa-pmph 2000 UNT/ML (SCDC, consists of)
- berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML [Keytruda Qlex] (SBDC, consists of)
- Injection (DF, has dose form)
- Keytruda Qlex (BN, has ingredient)
- 2.4 ML berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2723769 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2723769 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2723769. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.